Lead, genetic susceptibility, and risk of adult brain tumors.
Authors
Rajaraman-P; Stewart-PA; Samet-JM; Schwartz-BS; Linet-MS; Zahm-SH; Rothman-N; Yeager-M; Fine-HA; Black-PM; Loeffler-J; Shapiro-WR; Selker-RG; Inskip-PD
Source
Cancer Epidemiol Biomark Prev 2006 Dec; 15(12):2514-2520
Abstract
BACKGROUND: Although few etiologic factors for brain tumors have been identified, limited data suggest that lead may increase the risk of brain tumors, particularly meningioma. The ALAD G177C polymorphism affects the toxicokinetics of lead and may confer genetic susceptibility to adverse effects of lead exposure. METHODS: We examined occupational exposure to lead and risk of brain tumors in a multisite, hospital-based, case-control study of 489 patients with glioma, 197 with meningioma, and 799 non-cancer controls frequency matched on hospital, age, sex, race/ethnicity, and residential proximity to hospital. ALAD genotype was assessed by a Taqman assay for 355 glioma patients, 151 meningioma patients, and 505 controls. Exposure to lead was estimated using a rigorous questionnaire-based exposure assessment strategy incorporating lead measurement and other occupational data abstracted from published articles and reports. RESULTS: Increased risk of meningioma with occupational lead exposure (estimated by odds ratios and 95% confidence intervals) was most apparent in individuals with the ALAD2 variant allele, for whom risk increased from 1.1 (0.3-4.5) to 5.6 (0.7-45.5) and 12.8 (1.4-120.8) for estimated cumulative lead exposures of 1 to 49 microg/m3-y, 50 to 99 microg/m3-y, and >or=100 microg/m3-y, respectively, compared with unexposed individuals (two-sided P trend = 0.06). This relationship became stronger after excluding occupational lead exposures characterized by a low confidence level or occurring in the 10 years before meningioma diagnosis. Occupational lead exposure was not associated with glioma risk. CONCLUSIONS: Although our results indicate that lead may be implicated in meningioma risk in genetically susceptible individuals, these results need to be interpreted with caution given the small numbers of exposed cases with a variant genotype.
Keywords
Lead-absorption; Lead-poisoning; Brain-tumors; Brain-function; Neurological-system; Humans; Women; Men; Genetics; Blood-cells; Blood-disorders; Epidemiology; Occupational-exposure; Tumors
Contact
Preetha Rajaraman, Radiation Epidemiology Branch, National Cancer Institute, NIH, Department of Health and Human Services, 6120 Executive Boulevard, EPS Room 7085, Bethesda, MD 20892-7238
Document Type
Journal Article
Email Address
rajarama@mail.nih.gov
Identifying No.
Grant-Number-T42-OH-008428
Source Name
Cancer Epidemiology, Biomarkers & Prevention
Performing Organization
Johns Hopkins University
